Safinamide in Parkinson’s disease: No hint of added benefit

19 agosto 2015

Regarding Safinamide in Parkinson’s disease, reviewers state that since since relevant study data were not considered, analyses in the dossier were incomplete regarding serious side effects in the comparator therapy, long-term data and other aspects.
http://www.sciencedaily.com/releases/2015/08/150819103600.htm

Volver